Objective: Studies documenting the prevalence of delirium among critically ill children are still rare. Emerging literature from psychiatric specialists reports the prevalence of delirium to be approximately 10% in the pediatric intensive care unit (PICU). This is likely to be an underestimation of the true prevalence, as demonstrated in early adult delirium literature, especially given the absence of validated bedside tools to diagnose delirium in the PICU. The primary aim of this study is to validate the German version of the Pediatric Confusion Assessment Method for the Intensive Care Unit (pCAM-ICU). The secondary aim of the study is to compare validity and reliability of the pCAM-ICU and the Pediatric Anesthesia Emergence Delirium (PAED) Scale.
Study Type
OBSERVATIONAL
Enrollment
68
Department of Anesthesiology and Intensive Care Medicine, Campus Virchow Klinikum and Campus Charité mitte, Charité - Universitaetsmedizin Berlin
Berlin, Germany
Sensitivity of the pediatric confusing assessment method for the intensive care unit (pCAM-ICU)
Time frame: The participants will be followed up in the sample period (1 to 21 days)
Specifity of the pediatric confusing assessment method for the intensive care unit (pCAM-ICU)
Time frame: The participants will be followed up in the sample period (1 to 21 days)
Specifity of the Delirium Rating Scale (DRS)
Time frame: The participants will be followed up in the sample period (1 to 21 days)
Sensitivity of the Delirium Rating Scale (DRS)
Time frame: The participants will be followed up in the sample period (1 to 21 days)
Positive predictive value of the Delirium Rating Scale (DRS)
Time frame: The participants will be followed up in the sample period (1 to 21 days)
Prevalence of delirium
Measured with pediatric confusing assessment method for the intensive care unit (pCAM-ICU), Delirium Rating Scale (DRS) and DSM-IV-criteria
Time frame: The participants will be followed up in the sample period (1 to 21 days)
Depth of sedation
Measured with Richmond Agitation Sedation Scale (RASS)
Time frame: The participants will be followed up in the sample period (1 to 21 days)
Quality of Analgesia
Measured by Face Pain Scale, Revised (FPS-R) und the Numeric Analog Scale (NAS) or COMFORT Behavior-Scale.
Time frame: The participants will be followed up in the sample period (1 to 21 days)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.